The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension.
about
Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvesselsRedox signaling, vascular function, and hypertension.Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease.Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension.MMP-2 and sTNF-R1 Variability in Patients with Essential Hypertension: 1-Year Follow-Up Study.Matrix metalloproteinases as drug targets in preeclampsiaAn emerging role of degrading proteinases in hypertension and the metabolic syndrome: autodigestion and receptor cleavage.Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease.Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives.Expression of matrix metalloproteinases in patients with bipolar disorder.Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease.Estrogen deficiency-induced alterations of vascular MMP-2, MT1-MMP, and TIMP-2 in ovariectomized rats.Increased Circulating Tissue Inhibitor of Metalloproteinase-2 Is Associated With Resistant Hypertension.Resistance training and caloric restriction prevent systolic blood pressure rise by improving the nitric oxide effect on smooth muscle and morphological changes in the aorta of ovariectomized rats
P2860
Q24802679-705720DD-AD1C-4A2F-B5EE-9F17D5BDFBE4Q33689229-33252717-F277-4EAC-A2C5-5F6FAA8D56FAQ33872836-4FB847EB-584A-45FA-8420-61BBC3CB0DB7Q34009450-5417BF82-2249-4053-86E1-1AC3365A43CFQ36253578-922B98F4-C74A-4117-95CE-B3DBCD146F12Q36910638-78014782-0632-480A-8A06-21D4A3D2C079Q37955866-D6E17C1E-9819-43A8-9A8A-426E45C7AB6EQ38061567-CD6DDF9B-E0CE-4F1F-8301-B29FCF6308E6Q39208841-4345941C-A353-4BF9-9DC6-C00EC0902C2BQ45350830-B18197F9-7437-421A-9EB4-55C03FD6A126Q46069799-D1F5F35A-1157-4789-B5CC-2D2BEB17AFB2Q46235331-D0F75165-3C1F-4E8B-A2E5-43C89DC6EC31Q48161084-09F9230B-7FB0-4585-BCF8-DCDF53818796Q58723260-ACED927F-E2C8-416A-A450-AA0F424F1507
P2860
The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The effect of Ca2+ channel ant ...... -9 in essential hypertension.
@en
The effect of Ca2+ channel ant ...... -9 in essential hypertension.
@nl
type
label
The effect of Ca2+ channel ant ...... -9 in essential hypertension.
@en
The effect of Ca2+ channel ant ...... -9 in essential hypertension.
@nl
prefLabel
The effect of Ca2+ channel ant ...... -9 in essential hypertension.
@en
The effect of Ca2+ channel ant ...... -9 in essential hypertension.
@nl
P2093
P1476
The effect of Ca2+ channel ant ...... -9 in essential hypertension.
@en
P2093
Alexandra Zervoudaki
Christos Pitsavos
Constantina Aggeli
Emanuel Economou
Karmen Vasiliadou
Konstantinos Tsioufis
Marina Toutouza
Pavlos Toutouzas
P304
P356
10.1016/J.AMJHYPER.2003.11.007
P577
2004-03-01T00:00:00Z